See more news releases in: Medical Pharmaceuticals, Domestic Policy, FDA Approval
Cancer Medicines Pipeline Offers Patients Great Hope
WASHINGTON, Jan. 29 /PRNewswire-USNewswire/ -- The Bienville Democrat in Arcadia, LA recently reported that America's pharmaceutical research and biotechnology companies have made great progress in treating cancers, introducing many new, breakthrough medicines.
According to the article, scientists are currently working on 861 new cancer medicines that are either in late-stage testing, being used on patients in clinical trials or are being reviewed for approval by the Food and Drug Administration.
"A country that can put a man on the moon," says Billy Tauzin, president and CEO of the Pharmaceutical Research and Manufacturers of America, "can find a cure for cancer."
Despite the complexities, risks and high cost of development, America's pharmaceutical research and biotechnology companies continue to make large investments in the discovery and development of promising new medicines – and are working to find a cure for cancer and many other potentially deadly diseases.
SOURCE Pharmaceutical Research and Manufacturers of America
Back to top
RELATED LINKS
http://www.phrma.org/
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
PR Newswire Membership
Fill out a PR Newswire membership form or contact us at (888) 776-0942.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
Featured Video
More in These Categories
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Free Investing Newsletter from Investor Uprising!
Learn to navigate the world's financial system and profit from leading companies.
Register for Investor Uprising, the people's investment site, for a free weekly newsletter, information, education and premium research including our latest IU Confidential Report - "All The Glitters: The Ultimate Gold Report".